カテゴリー： GlobalInfoResearch, 世界, 部品/材料

世界の経口固形剤形（OSDF）＆医薬品添加剤市場2022年：グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他

◆英語タイトル：Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY1978）◆商品コード：GIR22MY1978
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：94
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

経口固形剤形（OSDF）＆医薬品添加剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経口固形剤形（OSDF）＆医薬品添加剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

経口固形剤形（OSDF）＆医薬品添加剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他

用途別セグメントは次のように区分されます。
・工業用、非工業用

世界の経口固形剤形（OSDF）＆医薬品添加剤市場の主要な市場プレーヤーは以下のとおりです。
・ABITEC Corporation、AkzoNobel、Archer Daniels Midland (ADM)、BASF、DowDuPont、Evonik、J.M. Huber Corporation、Cargill、Eastman Chemical Company

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経口固形剤形（OSDF）＆医薬品添加剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経口固形剤形（OSDF）＆医薬品添加剤メーカーの企業概要、2019年～2022年までの経口固形剤形（OSDF）＆医薬品添加剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経口固形剤形（OSDF）＆医薬品添加剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別経口固形剤形（OSDF）＆医薬品添加剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの経口固形剤形（OSDF）＆医薬品添加剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経口固形剤形（OSDF）＆医薬品添加剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および経口固形剤形（OSDF）＆医薬品添加剤の産業チェーンを掲載しています。
・第13、14、15章では、経口固形剤形（OSDF）＆医薬品添加剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：ABITEC Corporation、AkzoNobel、Archer Daniels Midland (ADM)、BASF、DowDuPont、Evonik、J.M. Huber Corporation、Cargill、Eastman Chemical Company
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他
・用途別分析2017年-2028年：工業用、非工業用
・経口固形剤形（OSDF）＆医薬品添加剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・経口固形剤形（OSDF）＆医薬品添加剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・経口固形剤形（OSDF）＆医薬品添加剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・経口固形剤形（OSDF）＆医薬品添加剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・経口固形剤形（OSDF）＆医薬品添加剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Oral Solid Dosage Forms (OSDF) and Pharma Excipients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market size is estimated to be worth US$ 992.4 million in 2021 and is forecast to a readjusted size of USD 1315.3 million by 2028 with a CAGR of 4.1% during review period. Industrial Application accounting for % of the Oral Solid Dosage Forms (OSDF) and Pharma Excipients global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Glycerin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Solid Dosage Forms (OSDF) and Pharma Excipients include ABITEC Corporation, AkzoNobel, Archer Daniels Midland (ADM), BASF, and DowDuPont, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Glycerin
Propylene Glycol
Sorbitol
Mannitol
Others
Market segment by Application can be divided into
Industrial Application
Non-industrial Application
The key market players for global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market are listed below:
ABITEC Corporation
AkzoNobel
Archer Daniels Midland (ADM)
BASF
DowDuPont
Evonik
J.M. Huber Corporation
Cargill
Eastman Chemical Company
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Solid Dosage Forms (OSDF) and Pharma Excipients product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Solid Dosage Forms (OSDF) and Pharma Excipients, with price, sales, revenue and global market share of Oral Solid Dosage Forms (OSDF) and Pharma Excipients from 2019 to 2022.
Chapter 3, the Oral Solid Dosage Forms (OSDF) and Pharma Excipients competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Solid Dosage Forms (OSDF) and Pharma Excipients breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Solid Dosage Forms (OSDF) and Pharma Excipients market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Solid Dosage Forms (OSDF) and Pharma Excipients.
Chapter 13, 14, and 15, to describe Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Glycerin
1.2.3 Propylene Glycol
1.2.4 Sorbitol
1.2.5 Mannitol
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Industrial Application
1.3.3 Non-industrial Application
1.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size & Forecast
1.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume (2017-2028)
1.4.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (2017-2028)
1.5 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity Analysis
1.5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Total Production Capacity (2017-2028)
1.5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
1.6.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints
1.6.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Trends Analysis
2 Manufacturers Profiles
2.1 ABITEC Corporation
2.1.1 ABITEC Corporation Details
2.1.2 ABITEC Corporation Major Business
2.1.3 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.1.4 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AkzoNobel
2.2.1 AkzoNobel Details
2.2.2 AkzoNobel Major Business
2.2.3 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.2.4 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Archer Daniels Midland (ADM)
2.3.1 Archer Daniels Midland (ADM) Details
2.3.2 Archer Daniels Midland (ADM) Major Business
2.3.3 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.3.4 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BASF
2.4.1 BASF Details
2.4.2 BASF Major Business
2.4.3 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.4.4 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 DowDuPont
2.5.1 DowDuPont Details
2.5.2 DowDuPont Major Business
2.5.3 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.5.4 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Evonik
2.6.1 Evonik Details
2.6.2 Evonik Major Business
2.6.3 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.6.4 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 J.M. Huber Corporation
2.7.1 J.M. Huber Corporation Details
2.7.2 J.M. Huber Corporation Major Business
2.7.3 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.7.4 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cargill
2.8.1 Cargill Details
2.8.2 Cargill Major Business
2.8.3 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.8.4 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eastman Chemical Company
2.9.1 Eastman Chemical Company Details
2.9.2 Eastman Chemical Company Major Business
2.9.3 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
2.9.4 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Breakdown Data by Manufacturer
3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Solid Dosage Forms (OSDF) and Pharma Excipients
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer Market Share in 2021
3.5 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Region
4.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2028)
4.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028)
4.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028)
4.4 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028)
4.5 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028)
4.6 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Type (2017-2028)
5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2028)
5.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Application (2017-2028)
6.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2028)
6.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
7.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
7.3 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country
7.3.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
8.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
8.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country
8.3.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Region
9.3.1 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
10.2 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
10.3 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country
10.3.1 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country
11.3.1 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Solid Dosage Forms (OSDF) and Pharma Excipients and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
12.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Process
12.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Typical Distributors
13.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ABITEC Corporation Basic Information, Manufacturing Base and Competitors
Table 4. ABITEC Corporation Major Business
Table 5. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 6. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AkzoNobel Basic Information, Manufacturing Base and Competitors
Table 8. AkzoNobel Major Business
Table 9. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 10. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Archer Daniels Midland (ADM) Basic Information, Manufacturing Base and Competitors
Table 12. Archer Daniels Midland (ADM) Major Business
Table 13. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 14. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. BASF Basic Information, Manufacturing Base and Competitors
Table 16. BASF Major Business
Table 17. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 18. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. DowDuPont Basic Information, Manufacturing Base and Competitors
Table 20. DowDuPont Major Business
Table 21. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 22. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Evonik Basic Information, Manufacturing Base and Competitors
Table 24. Evonik Major Business
Table 25. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 26. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. J.M. Huber Corporation Basic Information, Manufacturing Base and Competitors
Table 28. J.M. Huber Corporation Major Business
Table 29. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 30. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Cargill Basic Information, Manufacturing Base and Competitors
Table 32. Cargill Major Business
Table 33. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 34. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Eastman Chemical Company Basic Information, Manufacturing Base and Competitors
Table 36. Eastman Chemical Company Major Business
Table 37. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product and Services
Table 38. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Oral Solid Dosage Forms (OSDF) and Pharma Excipients, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Site of Key Manufacturer
Table 44. Oral Solid Dosage Forms (OSDF) and Pharma Excipients New Entrant and Capacity Expansion Plans
Table 45. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Mergers & Acquisitions in the Past Five Years
Table 46. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2022) & (K Units)
Table 47. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2023-2028) & (K Units)
Table 48. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 51. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 52. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 57. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 58. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 63. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 64. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 67. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 68. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 69. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 70. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 71. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 72. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 75. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 76. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 77. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 86. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2017-2022) & (K Units)
Table 87. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2023-2028) & (K Units)
Table 88. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 91. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 92. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 93. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2023-2028) & (K Units)
Table 102. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Raw Material
Table 103. Key Manufacturers of Oral Solid Dosage Forms (OSDF) and Pharma Excipients Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Typical Distributors
Table 107. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Typical Customers
List of Figures
Figure 1. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Picture
Figure 2. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type in 2021
Figure 3. Glycerin
Figure 4. Propylene Glycol
Figure 5. Sorbitol
Figure 6. Mannitol
Figure 7. Others
Figure 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application in 2021
Figure 9. Industrial Application
Figure 10. Non-industrial Application
Figure 11. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (2017-2028) & (K Units)
Figure 14. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (2017-2028) & (USD/Unit)
Figure 15. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity (2017-2028) & (K Units)
Figure 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
Figure 18. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints
Figure 19. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Trends
Figure 20. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Manufacturer in 2021
Figure 21. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Manufacturer in 2021
Figure 22. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2017-2028)
Figure 26. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2017-2028)
Figure 27. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028) & (USD Million)
Figure 28. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028) & (USD Million)
Figure 30. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (2017-2028) & (USD Million)
Figure 32. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2017-2028)
Figure 33. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type (2017-2028)
Figure 34. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2017-2028)
Figure 36. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application (2017-2028)
Figure 37. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2017-2028)
Figure 39. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2017-2028)
Figure 40. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2017-2028)
Figure 41. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2017-2028)
Figure 42. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2017-2028)
Figure 46. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2017-2028)
Figure 47. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2017-2028)
Figure 48. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2017-2028)
Figure 49. Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2017-2028)
Figure 58. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2017-2028)
Figure 65. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2017-2028)
Figure 66. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2017-2028)
Figure 67. South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients in 2021
Figure 79. Manufacturing Process Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
Figure 80. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の経口固形剤形（OSDF）＆医薬品添加剤市場2022年：グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他(Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 半固体投与量の世界市場見通し2023年-2029年
  • 世界のアルコール医薬品溶剤市場2022年：エタノール、イソプロパノール、プロパン、プロピレングリコール、その他
  • 世界のアルジトール市場2022年：ソルビトール、マンニトール、キシリトール、マルチトール、ラクチトール、エリスリトール、イソマルト、その他
  • 世界のOSDF用溶解度向上賦形剤市場2022年：固体分散、粒子サイズ縮小
  • 世界の溶解度向上剤市場2022年：固体分散、粒子サイズ縮小